References
Abelenda-Alonso, G., Padullés, A., Rombauts, A., Gudiol, C., Pujol, M., Alvarez-Pouso, C., Jodar, R., & Carratalà, J. (2020). Antibiotic prescription during the COVID-19 pandemic: A biphasic pattern.Infection control and hospital epidemiology , 41 (11), 1371–1372. https://doi.org/10.1017/ice.2020.381
Arshad, S., Kilgore, P., Chaudhry, Z. S., Jacobsen, G., Wang, D. D., Huitsing, K., Brar, I., Alangaden, G. J., Ramesh, M. S., McKinnon, J. E., O’Neill, W., Zervos, M., & Henry Ford COVID-19 Task Force (2020). Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases , 97 , 396–403. https://doi.org/10.1016/j.ijid.2020.06.099
Beović, B., Doušak, M., Ferreira-Coimbra, J., Nadrah, K., Rubulotta, F., Belliato, M., Berger-Estilita, J., Ayoade, F., Rello, J., & Erdem, H. (2020). Antibiotic use in patients with COVID-19: A ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey.Journal of Antimicrobial Chemotherapy , 75 (11), 3386–3390. https://doi.org/10.1093/jac/dkaa326
Bukhari, N., Rasheed, H., Nayyer, B., & Babar, Z.-U.-D. (2020). Pharmacists at the frontline beating the COVID-19 pandemic.Journal of Pharmaceutical Policy and Practice , 13 (1), 8. https://doi.org/10.1186/s40545-020-00210-w
Choi, K. R., Skrine Jeffers, K., & Cynthia Logsdon, M. (2020). Nursing and the novel coronavirus: Risks and responsibilities in a global outbreak. Journal of Advanced Nursing (John Wiley & Sons, Inc.) ,76 (7), 1486–1487. https://doi.org/10.1111/jan.14369
Collins, C. D., West, N., Sudekum, D. M., & Hecht, J. P. (2020). Perspectives from the frontline: A pharmacy department’s response to the COVID-19 pandemic. American Journal of Health-System Pharmacy ,77 (17), 1409–1416. https://doi.org/10.1093/ajhp/zxaa176
Feyaerts, A. F., & Luyten, W. (2020). Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19?. Nutrition (Burbank, Los Angeles County, Calif.), 79-80 , 110948. https://doi.org/10.1016/j.nut.2020.110948
Furtado, R., Berwanger, O., Fonseca, H. A., Corrêa, T. D., Ferraz, L. R., Lapa, M. G., Zampieri, F. G., Veiga, V. C., Azevedo, L., Rosa, R. G., Lopes, R. D., Avezum, A., Manoel, A., Piza, F., Martins, P. A., Lisboa, T. C., Pereira, A. J., Olivato, G. B., Dantas, V., Milan, E. P., … COALITION COVID-19 Brazil II Investigators (2020). Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet (London, England) , 396 (10256), 959–967. https://doi.org/10.1016/S0140-6736(20)31862-6
Gautret, P., Lagier, J. C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., Tissot Dupont, H., Honoré, S., Colson, P., Chabrière, E., La Scola, B., Rolain, J. M., Brouqui, P., & Raoult, D. (2020). Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International journal of antimicrobial agents , 56 (1), 105949. https://doi.org/10.1016/j.ijantimicag.2020.105949
Gourieux, B., Reisz, F., Belmas, A. S., Danion, F., Fourtage, M., Nai, T., Reiter-Schatz, A., Ruch, Y., Walther, J., Nivoix, Y., & Michel, B. (2020). Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital. European journal of hospital pharmacy: science and practice , ejhpharm-2020-002449. Advance online publication. https://doi.org/10.1136/ejhpharm-2020-002449
Guan, W.J., Ni, Z.Y., Hu, Y, et al. (2020). China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine ,382 , 1708–20.
Härtel, C., Strunk, T., Bucsky, P., & Schultz, C. (2004). Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes. Cytokine , 7 ;27(4-5), 101-106. https://doi: 10.1016/j.cyto.2004.02.004.
Jovic, T.H., Ali, S.R., Ibrahim, N., Jessop, Z.M., Tarassoli, S.P., Dobbs, T.D., Holford, P., Thornton, C.A., Whitaker, I.S. (2020). Could vitamins help in the fight against COVID-19? Nutrients. 12 :2550. https://doi: 10.3390/nu12092550.
Langford, B. J., So, M., Raybardhan, S., Leung, V., Westwood, D., MacFadden, D. R., Soucy, J. R., & Daneman, N. (2020). Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases , 26 (12), 1622–1629. https://doi.org/10.1016/j.cmi.2020.07.016
Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020). Co-infections in people with COVID-19: a systematic review and meta-analysis.The Journal of infection , 81 (2), 266–275. https://doi.org/10.1016/j.jinf.2020.05.046
Liew, Y., Lee, W., Tan, L., Kwa, A., Thien, S. Y., Cherng, B., & Chung, S. J. (2020). Antimicrobial stewardship programme: a vital resource for hospitals during the global outbreak of coronavirus disease 2019 (COVID-19). International journal of antimicrobial agents ,56 (5), 106145. https://doi.org/10.1016/j.ijantimicag.2020.106145
Liu, C., Wen, Y., Wan, W., Lei, J., & Jiang, X. (2020). Clinical characteristics and antibiotics treatment in suspected bacterial infection patients with COVID-19. International Immunopharmacology , 107157. https://doi.org/10.1016/j.intimp.2020.107157
Meščić Macan, A., Gazivoda Kraljević, T., & Raić-Malić, S. (2019) Therapeutic Perspective of Vitamin C and Its Derivatives.Antioxidants , 8 (8), 247. https://doi.org/10.3390/antiox8080247
Min, J. Y., & Jang, Y. J. (2012). Macrolide therapy in respiratory viral infections. Mediators of inflammation , 2012 , 649570. https://doi.org/10.1155/2012/649570
Mousavi, S., Bereswill, S., & Heimesaat, M.M. (2019). Immunomodulatory and Antimicrobial Effects of Vitamin C. European Journal of Microbiology and Immunology , 9 (3), 73-79. https://doi:10.1556/1886.2019.00016
Nestler, M. J., Godbout, E., Lee, K., Kim, J., Noda, A. J., Taylor, P., Pryor, R., Markley, J. D., Doll, M., Bearman, G., & Stevens, M. P. (2020). Impact of COVID-19 on pneumonia-focused antibiotic use at an academic medical center. Infection control and hospital epidemiology , 1–3. Advance online publication. https://doi.org/10.1017/ice.2020.362
Rawson, T. M., Ming, D., Ahmad, R., Moore, L. S. P., & Holmes, A. H. (2020a). Antimicrobial use, drug-resistant infections and COVID-19.Nature Reviews Microbiology , 18 (8), 409–410. https://doi.org/10.1038/s41579-020-0395-y
Rawson, T. M., Moore, L. S. P., Zhu, N., Ranganathan, N., Skolimowska, K., Gilchrist, M., Satta, G., Cooke, G., & Holmes, A. (2020b). Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.Clinical Infectious Diseases , 71 (9), 2459–2468. https://doi.org/10.1093/cid/ciaa530
Rodríguez-Álvarez, M., López-Vidal, Y., Soto-Hernández, J. L., Miranda-Novales, M. G., Flores-Moreno, K., & Ponce de León-Rosales, S. (2020). COVID-19: Clouds Over the Antimicrobial Resistance Landscape.Archives of Medical Research . https://doi.org/10.1016/j.arcmed.2020.10.010
Seaton, R. A., Gibbons, C. L., Cooper, L., Malcolm, W., McKinney, R., Dundas, S., Griffith, D., Jeffreys, D., Hamilton, K., Choo-Kang, B., Brittain, S., Guthrie, D., & Sneddon, J. (2020). Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals. Journal of Infection ,81 (6), 952–960. https://doi.org/10.1016/j.jinf.2020.09.024
Staub, M. B., Beaulieu, R. M., Graves, J., & Nelson, G. E. (2020). Changes in antimicrobial utilization during the coronavirus disease 2019 (COVID-19) pandemic after implementation of a multispecialty clinical guidance team. Infection control and hospital epidemiology , 1–7. Advance online publication. https://doi.org/10.1017/ice.2020.1291
Stevens, R. W., Jensen, K., O’Horo, J. C., & Shah, A. (2021). Antimicrobial prescribing practices at a tertiary-care center in patients diagnosed with COVID-19 across the continuum of care.Infection Control & Hospital Epidemiology , 42 (1), 89–92. https://doi.org/10.1017/ice.2020.370
Vaughn, V. M., Gandhi, T., Petty, L. A., Patel, P. K., Prescott, H. C., Malani, A. N., Ratz, D., McLaughlin, E., Chopra, V., & Flanders, S. A. (2020). Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-Hospital Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America , ciaa1239. Advance online publication. https://doi.org/10.1093/cid/ciaa1239
World Health Organization. (‎2020)‎. Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organization. https://apps.who.int/iris/handle/10665/332196.
Zhang, J., Zhou, L., Yang, Y., Peng, W., Wang, W., & Chen, X. (2020). Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics. The Lancet. Respiratory medicine , 8 (3), e11–e12. https://doi.org/10.1016/S2213-2600(20)30071-0